Cargando…

The comparative effects of oral Chinese patent medicines in non-proliferative diabetic retinopathy: A Bayesian network meta-analysis of randomized controlled trials

BACKGROUND: Non-proliferative diabetic retinopathy (NPDR), a common diabetic complication with high morbidity, is featured by impaired visual function and fundus lesions. It has been reported that oral Chinese patent medicines (OCPMs) may improve visual acuity and fund signs. However, the best possi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ziqiang, Chen, Yunru, Jie, Chuanhong, Wang, Jianwei, Deng, Yu, Hou, Xiaoyu, Li, Yuanyuan, Cai, Wenjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106679/ https://www.ncbi.nlm.nih.gov/pubmed/37077355 http://dx.doi.org/10.3389/fendo.2023.1144290

Ejemplares similares

Effect of Chinese Patent Medicines on Ocular Fundus Signs and Vision in Calcium Dobesilate-Treated Persons With Non-Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis
por: Zhang, Yuehong, et al.
Publicado: (2022)

Systematic evaluation of combined herbal adjuvant therapy for proliferative diabetic retinopathy
por: Huai, Baogeng, et al.
Publicado: (2023)

Evaluation of retina and microvascular changes in the patient with Parkinson’s disease: A systematic review and meta-analysis
por: Deng, Yu, et al.
Publicado: (2022)

The relationship between renal function and surgical outcomes of patients with proliferative diabetic retinopathy
por: Liu, Jin, et al.
Publicado: (2022)

Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy
por: Wang, Weiwei, et al.
Publicado: (2023)

Exploring the Immune Infiltration Landscape and M2 Macrophage-Related Biomarkers of Proliferative Diabetic Retinopathy
por: Meng, Zhishang, et al.
Publicado: (2022)

Comparative efficacy and safety of traditional Chinese patent medicine for endometriosis: A Bayesian network meta-analysis protocol
por: Dong, Shuangqian, et al.
Publicado: (2019)

Effect of Chinese herbal compounds on ocular fundus signs and vision in conventional treated-persons with non-proliferative diabetic retinopathy: A systematic review and meta-analysis
por: Li, Xiaodong, et al.
Publicado: (2022)

Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis
por: Xie, Xiao, et al.
Publicado: (2023)

Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy
por: Yang, Zhikun, et al.
Publicado: (2023)

Novel risk score model for non-proliferative diabetic retinopathy based on untargeted metabolomics of venous blood
por: Wang, Xinyu, et al.
Publicado: (2023)

Retina and microvascular alterations in migraine: a systemic review and meta-analysis
por: Liu, Ziqiang, et al.
Publicado: (2023)

Altered Expressions of Transfer RNA-Derived Small RNAs and microRNAs in the Vitreous Humor of Proliferative Diabetic Retinopathy
por: Yang, Yan, et al.
Publicado: (2022)

Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis
por: Zhang, Dan, et al.
Publicado: (2020)

Effectiveness and Safety of Oral Chinese Patent Medicines Combined with Chemotherapy for Gastric Cancer: A Bayesian Network Meta-Analysis
por: Lu, Xiaona, et al.
Publicado: (2020)

A Chinese Patent Medicine JiaYanKangTai Alleviates Inflammatory Lesions of Experimental Autoimmune Thyroiditis by Regulating Interleukin-17 Signaling
por: Pan, Yajing, et al.
Publicado: (2022)

The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy
por: Lei, Chunyan, et al.
Publicado: (2022)

Decreased expression of Glucagon-like peptide-1 receptor and Sodium-glucose co-transporter 2 in patients with proliferative diabetic retinopathy
por: Chen, Hui, et al.
Publicado: (2022)

Traditional Chinese Patent Medicine for Primary Hypertension: A Bayesian Network Meta-Analysis
por: Chen, Zhe, et al.
Publicado: (2020)

Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
por: Xu, Kai, et al.
Publicado: (2022)

A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy
por: Sun, Yaoyao, et al.
Publicado: (2023)

Oral traditional Chinese patent medicines combined with non-steroidal anti-inflammatory drugs for primary dysmenorrhea: A protocol for Bayesian network meta-analysis and systematic review
por: Chen, Zhe, et al.
Publicado: (2022)

Effects of a Chinese Patent Medicine Gushen’antai Pills on Ongoing Pregnancy Rate of Hormone Therapy FET Cycles: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Cao, Xian-ling, et al.
Publicado: (2020)

Advances in targeted retinal photocoagulation in the treatment of diabetic retinopathy
por: Lin, Zichun, et al.
Publicado: (2023)

The correlation between peripheral complete blood count parameters and diabetic macular edema in proliferative diabetic retinopathy patients: a cross-sectional study
por: Lei, Chunyan, et al.
Publicado: (2023)

Retinal vein changes in patients with high-risk proliferative diabetic retinopathy treated with conbercept and panretinal photocoagulation co-therapy: a cohort study
por: Si, Mingwei, et al.
Publicado: (2023)

Oral proprietary Chinese medicine for lupus nephritis: A bayesian network meta-analysis
por: Lin, Aitao, et al.
Publicado: (2023)

Influencing factors on compliance of timely visits among patients with proliferative diabetic retinopathy in southern China: a qualitative study
por: Duan, Fang, et al.
Publicado: (2017)

DNA based identification of medicinal materials in Chinese patent medicines
por: Chen, Rong, et al.
Publicado: (2012)

The Association of Homocysteine and Diabetic Retinopathy in Homocysteine Cycle in Chinese Patients With Type 2 Diabetes
por: Luo, Wei-Ming, et al.
Publicado: (2022)

Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment
por: Deng, Chujun, et al.
Publicado: (2022)

Long-Term Oral Administration of Salidroside Alleviates Diabetic Retinopathy in db/db Mice
por: Yao, Fei, et al.
Publicado: (2022)

Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study
por: Li, Jiangtao, et al.
Publicado: (2022)

Identification of the Chinese Population That Can Benefit Most From Postprandial Lipid Testing: Validation of the Use of Oral Fat Tolerance Testing in Clinical Practice
por: Hou, Xiaoyu, et al.
Publicado: (2022)

Efficacy of calcium dobesilate in treating Chinese patients with mild-to-moderate non-proliferative diabetic retinopathy (CALM-DR): protocol for a single-blind, multicentre, 24-armed cluster-randomised, controlled trial
por: Hu, Hao, et al.
Publicado: (2021)

Effectiveness comparisons of Chinese patent medicine on sciatica: A protocol for systematic review and Bayesian network meta-analysis
por: An, Hongqiang, et al.
Publicado: (2020)

Chinese patent medicine for functional dyspepsia effects: A protocol for systematic review and Bayesian network meta-analysis
por: Wu, Jingjie, et al.
Publicado: (2021)

Effectiveness comparisons of Chinese patent medicine on insomnia: A protocol for systematic review and Bayesian network meta-analysis
por: Chao, Ruoyu, et al.
Publicado: (2021)

Comparative efficacy of Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta− analysis
por: Su, Wenquan, et al.
Publicado: (2023)

Corrigendum: Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study
por: Li, Jiangtao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ocpa3ojoi4b0nv4o10rbq7adj6